NHS National Generics Pharmaceuticals - Supply Chain Resilience
key details
| Value | £52,447,296 (£62,936,755 inc. VAT) |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West |
| Deadline | 6 Mar 2026 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-h6vhtk-060abf |
Awards (33)
This procurement was awarded to 26 suppliers. Values shown are per-award; the notice total is £52,447,296.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord UK Ltd shared | £35,010,320 | 30 Apr 2026 | active |
| Amarox Limited shared | £35,010,320 | 30 Apr 2026 | active |
| Amarox Limited shared | £4,213,176 | 30 Apr 2026 | active |
| Ascend Laboratories shared | £35,010,320 | 30 Apr 2026 | active |
| Aspire Pharma Limited shared | £35,010,320 | 30 Apr 2026 | active |
| Aspire Pharma Limited shared | £4,213,176 | 30 Apr 2026 | active |
| Baxter Healthcare Ltd shared | £35,010,320 | 30 Apr 2026 | active |
| Brown and Burk UK Ltd shared | £35,010,320 | 30 Apr 2026 | active |
| Cipla (EU) Limited shared | £35,010,320 | 30 Apr 2026 | active |
| Cipla (EU) Limited shared | £4,213,176 | 30 Apr 2026 | active |
| Colonis Pharma Ltd shared | £4,213,176 | 30 Apr 2026 | active |
| Crescent Pharma Limited shared | £4,213,176 | 30 Apr 2026 | active |
| Day Lewis Medical Ltd shared | £4,213,176 | 30 Apr 2026 | active |
| Ennogen Healthcare International Limited shared | £4,213,176 | 30 Apr 2026 | active |
| Fresenius Kabi Limited shared | £35,010,320 | 30 Apr 2026 | active |
| Glenmark Pharmaceuticals (Europe) Ltd shared | £35,010,320 | 30 Apr 2026 | active |
| G.L. Pharma UK Limited shared | £4,213,176 | 30 Apr 2026 | active |
| Hikma Pharmaceuticals International Ltd shared | £35,010,320 | 30 Apr 2026 | active |
| Jannsen-Cilag Limited shared | £35,010,320 | 30 Apr 2026 | active |
| MACARTHYS LABORATORIES LIMITED shared | £35,010,320 | 30 Apr 2026 | active |
| Milpharm Limited shared | £35,010,320 | 30 Apr 2026 | active |
| Milpharm Limited shared | £4,213,176 | 30 Apr 2026 | active |
| Morningside Pharmaceuticals Ltd shared | £4,213,176 | 30 Apr 2026 | active |
| Northumbria Pharma Limited shared | £4,213,176 | 30 Apr 2026 | active |
| Selective Supplies Limited shared | £4,213,176 | 30 Apr 2026 | active |
| Sun Pharma UK Limited shared | £35,010,320 | 30 Apr 2026 | active |
| Teva UK Limited shared | £35,010,320 | 30 Apr 2026 | active |
| Teva UK Limited shared | £4,213,176 | 30 Apr 2026 | active |
| Viatris UK Healthcare Limited shared | £35,010,320 | 30 Apr 2026 | active |
| Wockhardt UK Limited shared | £35,010,320 | 30 Apr 2026 | active |
| Wockhardt UK Limited shared | £4,213,176 | 30 Apr 2026 | active |
| Zentiva Pharma UK Limited shared | £35,010,320 | 30 Apr 2026 | active |
| Zentiva Pharma UK Limited shared | £4,213,176 | 30 Apr 2026 | active |
description
NHS National Generics Pharmaceuticals - Supply Chain Resilience
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.
Periods of call-offs under the framework agreement:
CM/PHG/25/5739/01 – Orals (plus non-parenteral) Products
CESW: (Midlands and Southwest): 1st September 2026 to 31st May 2028 (21 months)
NWLN: (Northwest and London North): 1st September 2026 to 31st May 2028 (21 months)
LSNE: (London South and Northeast): 1st September 2026 to 31st May 2028 (21 months)
CM/PHG/25/5739/02 – Hospital Only Products
DLS (London South) & DNE (North-East): 1st September 2026 to 31st May 2028 (21 months)
DLN (London North) & DNW (North-West): 1st September 2026 to 31st May 2028 (21 months)
DCE (Central/Midlands) & DSW (South-West): 1st September 2026 to 30th September 2027 (13 months)
This tender is for lines that have recently been terminated or unable to be awarded on previous tenders. Please note we have previously referred to these as “Housekeeping” tenders.
documents
- https://www.find-tender.service.gov.uk/Notice/008328-2026 , tenderNotice
- https://www.find-tender.service.gov.uk/Notice/008379-2026 , tenderNotice
- https://www.find-tender.service.gov.uk/Notice/017481-2026 , tenderNotice
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-11220 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-12671 , biddingDocuments
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
6 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 21 Jan 2026 | Preliminary market engagement (UK2) | Procurement Act 2023 | 005168-2026 |
| 30 Jan 2026 | Tender notice (UK4) | Procurement Act 2023 | 008328-2026 |
| 30 Jan 2026 | Tender notice (UK4) | Procurement Act 2023 | 008379-2026 |
| 26 Feb 2026 | Tender notice (UK4) | Procurement Act 2023 | 017481-2026 |
| 1 May 2026 | Contract award (UK6) | Procurement Act 2023 | 040594-2026 |
| 6 Jul 2026 | Contract details (UK7) | Procurement Act 2023 | 063339-2026 |
more from NHS England
- Coaching services for trainee doctors, dentists and pharmacists · £36,000 · 30 Jul 2026
- Exam Support Packages for EoE GP Registrars · £72,673 · 24 Jul 2026
- Refer a Patient - Adult ECMO 2026/27 · £99,362 · 23 Jul 2026
- Higher Specialist Scientist Training Programme (HSST) · £42,186,231 · 23 Jul 2026
- Imaging National Lecture Series · £400,000 · 22 Jul 2026
- NHS National Framework for Lenvatinib · £35,833,000 · 22 Jul 2026
- The Practice Education Facilitator role in Return to Practice · £20,000 · 22 Jul 2026
- Pharmacy Technician Clinical Skills Development · £300,000 · 22 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
- LW158 IMP Support (FAME) · Liverpool School of Tropical Medicine · £0
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.